Evidence map›Paper›PMID 31853172›Full record

ArticleDrug design, development and therapy2019

Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.

Junqi Wu, Jinwei Dai, Yuyang Zhang, Jing Wang, Lei Huang, Hongmei Ding, Tiejun Li, Yuefan Zhang, Junqin Mao, Shichong Yu

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Application of triazoles in the structural modification of natural products.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  3. Review
  4. Review
  5. Anti-Tumor Xanthones fromDrug design, development and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Junqi Wu *College of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Jinwei Dai *College of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Yuyang ZhangCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.ORCID 0000-0002-7759-1211
Jing WangCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Lei HuangCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Hongmei DingCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Tiejun LiCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Yuefan ZhangCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Junqin MaoDepartment of Pharmacy, Shanghai Pudong New Area People's Hospital, Shanghai 201299, People's Republic of China.
Shichong YuCollege of Pharmacy, Naval Medical University, Shanghai 200433, People's Republic of China.
Shenyang Pharmaceutical University · CNPudong New Area People's Hospital · CNPunan Hospital · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeXanthones demonstrated an array of pharmacological activities via non-covalent DNA interaction and have been widely utilized in new drug research. The introduction of the polar 1,2,3-triazole ring located at the C3-position of xanthone has not been reported thus far.

methodsIn the present study, a series of xanthone derivatives were designed, synthesized, and characterized through

resultsThe IC

conclusionWe synthesized several derivatives of xanthone and evaluated their cytotoxicity. The evidence suggested that compound 1j possessed greater anticancer potential for further evaluations.

Indexed as

A549 CellsAntineoplastic AgentsCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansMolecular StructureStructure-Activity RelationshipXanthonesAntineoplastic AgentsxanthoneXanthonesapoptosisderivativeslung cancer cellsynthesisxanthone

Identifiers

PMID31853172
PMCPMC6916687
OpenAlexW2994893080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.